首页 > 最新文献

Health Policy and Technology最新文献

英文 中文
Towards a universal patient-centric health record sharing platform 建立一个以患者为中心的通用健康记录共享平台
IF 6 3区 医学 Q1 HEALTH POLICY & SERVICES Pub Date : 2023-10-14 DOI: 10.1016/j.hlpt.2023.100819
Mana Azarm , Rebecca Meehan , Craig Kuziemsky
<div><h3>Objectives</h3><p>This paper provides a practical approach to evaluate health record sharing platforms in terms of their ability to deliver interoperable healthcare of quality at a systems level. We use our previously published interoperability evaluation framework to evaluate our proposed System-level Record Sharing (SLRS) platform against four other common categories of health record sharing platforms in Canada, the United States, and Norway.</p></div><div><h3>Methods</h3><p>In this paper, we compare the SLRS platform architecture that we previously developed against 4 health record sharing platform categories. We conducted this comparative evaluation of 5 categories of healthcare platforms: SLRS, Commercial-Multi (CM), Commercial-Independent (CI), Governmental-Multi (GM), and Governmental-Independent (GI) using our proposed evaluation framework that is built upon quadruple aim, triple aim and Canadian Institute for Health Information (CIHI) health platform evaluation frameworks.</p></div><div><h3>Results</h3><p>SLRS and platforms managed by government organizations that provide a technology-independent or compatible platform were the most effective in terms of satisfying data interoperability, providing meaningful and effective information exchange, being compliant with health privacy regulations across a range of contexts, and having many of the costs paid for at a central level. All platforms struggled with context and process interoperability requirements, as well as providing evidence-based information across an entire health system.</p></div><div><h3>Conclusion</h3><p>To optimize health management, both clinicians and patients need sharing of personal health information (PHI) across applications. Our findings indicate that commercial platforms in this study need to improve their governance structure and employ a consistent ontology that can be adopted by all EHR applications across a health system. Our proposed SLRS platform can support the sharing of health data across multiple health care organizations at a system-level, allowing clinicians to access patient health data to inform treatment and care decisions.</p></div><div><h3>Public interest abstract</h3><p>Healthcare organizations face barriers when exchanging information across their boundaries. Many obstacles are caused by varying technical requirements of the EHR applications they have, and their contextual regulations. Most healthcare organizations have a portal in which the patients can view their care history. However, the breadth of the information provided limits to the number of healthcare providers subscribed to that specific platform. Viewing the full history across the entire health system, requires maintaining multiple accounts.</p><p>In this paper we refer to a new framework for sharing health information and its prototyped platform (SLRS) that we have previously developed in our lab. In this paper we report on how we evaluated the SLRS platform against four pro
目的本文提供了一种实用的方法来评估健康记录共享平台在系统级别提供可互操作的高质量医疗保健的能力。我们使用我们之前发布的互操作性评估框架,将我们提出的系统级记录共享(SLRS)平台与加拿大、美国和挪威的其他四类常见的健康记录共享平台进行评估。我们使用我们提出的基于四重目标、三重目标和加拿大卫生信息研究所(CIHI)健康平台评估框架的评估框架,对5类医疗平台进行了比较评估:SLRS、商业多平台(CM)、商业独立平台(CI)、政府多平台(GM)和政府独立平台(GI)。结果SLRS和由政府组织管理的提供技术独立或兼容平台的平台在满足数据互操作性、提供有意义和有效的信息交换、在各种情况下遵守健康隐私法规以及在中央层面支付许多成本方面是最有效的。所有平台都在努力满足上下文和流程互操作性要求,并在整个卫生系统中提供循证信息。结论为了优化健康管理,临床医生和患者都需要跨应用程序共享个人健康信息(PHI)。我们的研究结果表明,本研究中的商业平台需要改进其治理结构,并采用可被整个卫生系统的所有EHR应用程序采用的一致本体。我们提出的SLRS平台可以在系统级别支持多个医疗保健组织之间的健康数据共享,使临床医生能够访问患者健康数据,为治疗和护理决策提供信息。公共利益抽象医疗保健组织在跨国界交换信息时面临障碍。许多障碍是由EHR应用程序的不同技术要求及其上下文规定造成的。大多数医疗机构都有一个门户网站,患者可以在其中查看他们的护理历史。然而,所提供信息的广度限制了订阅该特定平台的医疗保健提供者的数量。查看整个卫生系统的完整历史记录需要维护多个帐户。在本文中,我们参考了一个新的健康信息共享框架及其原型平台(SLRS),该框架是我们之前在实验室中开发的。在本文中我们报告了我们如何根据健康信息交换的四个突出实践来评估SLRS平台。我们使用了我们的互操作性评估框架,该框架是根据文献和实践中公认的标准开发的。我们发现了现有健康信息平台需要改进的地方,这样他们就可以在整个卫生系统中共享自己的记录。
{"title":"Towards a universal patient-centric health record sharing platform","authors":"Mana Azarm ,&nbsp;Rebecca Meehan ,&nbsp;Craig Kuziemsky","doi":"10.1016/j.hlpt.2023.100819","DOIUrl":"https://doi.org/10.1016/j.hlpt.2023.100819","url":null,"abstract":"&lt;div&gt;&lt;h3&gt;Objectives&lt;/h3&gt;&lt;p&gt;This paper provides a practical approach to evaluate health record sharing platforms in terms of their ability to deliver interoperable healthcare of quality at a systems level. We use our previously published interoperability evaluation framework to evaluate our proposed System-level Record Sharing (SLRS) platform against four other common categories of health record sharing platforms in Canada, the United States, and Norway.&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Methods&lt;/h3&gt;&lt;p&gt;In this paper, we compare the SLRS platform architecture that we previously developed against 4 health record sharing platform categories. We conducted this comparative evaluation of 5 categories of healthcare platforms: SLRS, Commercial-Multi (CM), Commercial-Independent (CI), Governmental-Multi (GM), and Governmental-Independent (GI) using our proposed evaluation framework that is built upon quadruple aim, triple aim and Canadian Institute for Health Information (CIHI) health platform evaluation frameworks.&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Results&lt;/h3&gt;&lt;p&gt;SLRS and platforms managed by government organizations that provide a technology-independent or compatible platform were the most effective in terms of satisfying data interoperability, providing meaningful and effective information exchange, being compliant with health privacy regulations across a range of contexts, and having many of the costs paid for at a central level. All platforms struggled with context and process interoperability requirements, as well as providing evidence-based information across an entire health system.&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Conclusion&lt;/h3&gt;&lt;p&gt;To optimize health management, both clinicians and patients need sharing of personal health information (PHI) across applications. Our findings indicate that commercial platforms in this study need to improve their governance structure and employ a consistent ontology that can be adopted by all EHR applications across a health system. Our proposed SLRS platform can support the sharing of health data across multiple health care organizations at a system-level, allowing clinicians to access patient health data to inform treatment and care decisions.&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Public interest abstract&lt;/h3&gt;&lt;p&gt;Healthcare organizations face barriers when exchanging information across their boundaries. Many obstacles are caused by varying technical requirements of the EHR applications they have, and their contextual regulations. Most healthcare organizations have a portal in which the patients can view their care history. However, the breadth of the information provided limits to the number of healthcare providers subscribed to that specific platform. Viewing the full history across the entire health system, requires maintaining multiple accounts.&lt;/p&gt;&lt;p&gt;In this paper we refer to a new framework for sharing health information and its prototyped platform (SLRS) that we have previously developed in our lab. In this paper we report on how we evaluated the SLRS platform against four pro","PeriodicalId":48672,"journal":{"name":"Health Policy and Technology","volume":"12 4","pages":"Article 100819"},"PeriodicalIF":6.0,"publicationDate":"2023-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"50197905","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Telemedicine implementation framework for Malaysia: An integrated SWOT-MCDM approach 马来西亚远程医疗实施框架:SWOT-MCDM综合方法
IF 6 3区 医学 Q1 HEALTH POLICY & SERVICES Pub Date : 2023-10-13 DOI: 10.1016/j.hlpt.2023.100818
Siti Norida Wahab , Jagroop Singh , Nikram Subramaniam

Objectives

Despite the increase in the utilization of telemedicine worldwide, especially during the pandemic, its implementation in Malaysia's healthcare industry remains scarce. Hence, this study aims to understand the current state of telemedicine utilization by identifying the constraints and establishing the optimum telemedicine implementation strategy.

Methods

The study proposes an integrated methodology based on strengths, weaknesses, opportunities, and threats (SWOT) analysis, analytical hierarchy process entropy (AHPE), and fuzzy technique for order performance by similarity to the ideal solution (FTOPSIS). The SWOT analysis is performed for the situational assessment of telemedicine technology in Malaysia. Each element of SWOT was assessed using AHPE to establish priorities, followed by the FTOPSIS approach to provide strategies for its successful adoption.

Results

The findings show that continuous government support and encouragement for market acquisition, cost-cutting, profit-maximizing, and Internet of Things (IoT)-based adoption to establish a strong telemedicine network is the most important strategy for telemedicine technology implementation. While using a structured method to improve service quality, the implementation of a knowledge-sharing management program for telemedicine technology is ranked as the least preferred telemedicine technology implementation strategy.

Conclusions

The study suggests a systematic way of developing and evaluating telemedicine technology implementation strategies for further improving Malaysian healthcare patient experiences and policy endeavours. This study proposed alternative strategies to expand telemedicine technology implementation. It is hoped that this study could further enhance knowledge and serve as a guide for stakeholders in the healthcare industry to understand their business environment better.

目的尽管远程医疗在全球范围内的使用有所增加,特别是在疫情期间,但在马来西亚医疗保健行业的实施仍然很少。因此,本研究旨在通过识别制约因素和制定最佳远程医疗实施策略来了解远程医疗利用的现状。方法提出了一种基于优势、劣势、机会和威胁(SWOT)分析、层次分析过程熵(AHPE)和基于理想解相似性的订单绩效模糊技术(FTOPSIS)的综合方法。对马来西亚远程医疗技术的现状进行SWOT分析。SWOT的每个要素都使用AHPE进行评估,以确定优先事项,然后使用FTOPSIS方法为其成功采用提供战略。结果研究结果表明,政府持续支持和鼓励市场收购、成本削减、利润最大化和基于物联网的采用,以建立强大的远程医疗网络,是远程医疗技术实施的最重要战略。在使用结构化方法提高服务质量的同时,实施远程医疗技术的知识共享管理计划被列为最不受欢迎的远程医疗技术实施策略。结论该研究为制定和评估远程医疗技术实施策略提供了一种系统的方法,以进一步改善马来西亚医疗患者的体验和政策努力。这项研究提出了扩大远程医疗技术实施的替代策略。希望这项研究能够进一步增强知识,并为医疗保健行业的利益相关者更好地了解他们的商业环境提供指导。
{"title":"Telemedicine implementation framework for Malaysia: An integrated SWOT-MCDM approach","authors":"Siti Norida Wahab ,&nbsp;Jagroop Singh ,&nbsp;Nikram Subramaniam","doi":"10.1016/j.hlpt.2023.100818","DOIUrl":"https://doi.org/10.1016/j.hlpt.2023.100818","url":null,"abstract":"<div><h3>Objectives</h3><p>Despite the increase in the utilization of telemedicine worldwide, especially during the pandemic, its implementation in Malaysia's healthcare industry remains scarce. Hence, this study aims to understand the current state of telemedicine utilization by identifying the constraints and establishing the optimum telemedicine implementation strategy.</p></div><div><h3>Methods</h3><p>The study proposes an integrated methodology based on strengths, weaknesses, opportunities, and threats (SWOT) analysis, analytical hierarchy process entropy (AHPE), and fuzzy technique for order performance by similarity to the ideal solution (FTOPSIS). The SWOT analysis is performed for the situational assessment of telemedicine technology in Malaysia. Each element of SWOT was assessed using AHPE to establish priorities, followed by the FTOPSIS approach to provide strategies for its successful adoption.</p></div><div><h3>Results</h3><p>The findings show that continuous government support and encouragement for market acquisition, cost-cutting, profit-maximizing, and Internet of Things (IoT)-based adoption to establish a strong telemedicine network is the most important strategy for telemedicine technology implementation. While using a structured method to improve service quality, the implementation of a knowledge-sharing management program for telemedicine technology is ranked as the least preferred telemedicine technology implementation strategy.</p></div><div><h3>Conclusions</h3><p>The study suggests a systematic way of developing and evaluating telemedicine technology implementation strategies for further improving Malaysian healthcare patient experiences and policy endeavours. This study proposed alternative strategies to expand telemedicine technology implementation. It is hoped that this study could further enhance knowledge and serve as a guide for stakeholders in the healthcare industry to understand their business environment better.</p></div>","PeriodicalId":48672,"journal":{"name":"Health Policy and Technology","volume":"12 4","pages":"Article 100818"},"PeriodicalIF":6.0,"publicationDate":"2023-10-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"50197879","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Must the ICMJE and COPE guidelines and/or recommendations be interpreted (and used) as voluntary advice or as mandatory rules? ICMJE和COPE指南和/或建议是否必须被解释(和使用)为自愿建议或强制性规则?
IF 6 3区 医学 Q1 HEALTH POLICY & SERVICES Pub Date : 2023-10-12 DOI: 10.1016/j.hlpt.2023.100817
Jaime A. Teixeira da Silva
{"title":"Must the ICMJE and COPE guidelines and/or recommendations be interpreted (and used) as voluntary advice or as mandatory rules?","authors":"Jaime A. Teixeira da Silva","doi":"10.1016/j.hlpt.2023.100817","DOIUrl":"https://doi.org/10.1016/j.hlpt.2023.100817","url":null,"abstract":"","PeriodicalId":48672,"journal":{"name":"Health Policy and Technology","volume":"12 4","pages":"Article 100817"},"PeriodicalIF":6.0,"publicationDate":"2023-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"50197904","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Factors affecting the use of magnetic resonance imaging in a Southern European region: a qualitative study 影响南欧地区磁共振成像使用的因素:一项定性研究
IF 6 3区 医学 Q1 HEALTH POLICY & SERVICES Pub Date : 2023-10-08 DOI: 10.1016/j.hlpt.2023.100816
Yolanda González-Rábago , Erika Valero , Paola Bully , Pedro Latorre , Begoña Fernandez-Ruanova

Objectives

The use of Magnetic Resonance Imaging (MRI) has increased significantly in recent years. Superior diagnostic capability and extension of criteria for the performance of MRI may explain this increase, but there are also non-clinical factors that influence doctors’ decisions. We aim to describe the views of doctors in the Basque Country (Spain) regarding factors affecting MRI orders.

Methods

We conducted a qualitative study using semi-structured interviews with doctors based on intentional sampling to cover a diverse range of interviewees according to personal and professional characteristics (sex, workplace, post of responsibility). We analyzed transcript content using an inductive approach.

Results

Factors identified by doctors were classified into three themes: 1) superior diagnostic capability of the MRI compared to other imaging modalities has favoured MRI use and inclusion in Clinical Practice Guidelines; 2) patient demands, owing to lower trust and acceptance of doctors’ judgment than to technology-based medicine, leads to patient-doctor relationships that result unnecessary MRI test; 3) structural or contextual aspects of the health system, such as excessive rotation of doctors or a lack of time to carry out a thorough patient examination, which disempower doctors and favour overuse.

Conclusions

Doctors identified non-clinical factors that affect MRI use and that lead to unintended consequences both for the healthcare system and for patients. We recommend an organizational approach to give doctors enough resources to overcome non-clinical factors that lead to excessive MRI orders in order to optimize its use.

目的近年来磁共振成像(MRI)的应用显著增加。优越的诊断能力和MRI性能标准的扩展可能解释了这种增加,但也有非临床因素影响医生的决定。我们的目的是描述巴斯克地区(西班牙)医生对影响MRI医嘱的因素的看法。方法我们根据个人和职业特征(性别、工作场所、责任岗位),采用有意抽样的方法,对医生进行了半结构化访谈,以涵盖不同范围的受访者。我们使用归纳法分析了成绩单内容。结果医生确定的因素分为三个主题:1)与其他成像方式相比,MRI的诊断能力优越,有利于MRI的使用和纳入临床实践指南;2) 与基于技术的医学相比,由于对医生判断的信任和接受度较低,患者需求导致了医患关系,导致了不必要的MRI检查;3) 卫生系统的结构或背景方面,如医生过度轮换或缺乏时间对患者进行彻底检查,这剥夺了医生的权力,有利于过度使用。结论医生发现了影响MRI使用的非临床因素,这些因素会对医疗系统和患者造成意想不到的后果。我们建议采用一种组织方法,为医生提供足够的资源,以克服导致MRI订单过多的非临床因素,从而优化其使用。
{"title":"Factors affecting the use of magnetic resonance imaging in a Southern European region: a qualitative study","authors":"Yolanda González-Rábago ,&nbsp;Erika Valero ,&nbsp;Paola Bully ,&nbsp;Pedro Latorre ,&nbsp;Begoña Fernandez-Ruanova","doi":"10.1016/j.hlpt.2023.100816","DOIUrl":"https://doi.org/10.1016/j.hlpt.2023.100816","url":null,"abstract":"<div><h3>Objectives</h3><p>The use of Magnetic Resonance Imaging (MRI) has increased significantly in recent years. Superior diagnostic capability and extension of criteria for the performance of MRI may explain this increase, but there are also non-clinical factors that influence doctors’ decisions. We aim to describe the views of doctors in the Basque Country (Spain) regarding factors affecting MRI orders.</p></div><div><h3>Methods</h3><p>We conducted a qualitative study using semi-structured interviews with doctors based on intentional sampling to cover a diverse range of interviewees according to personal and professional characteristics (sex, workplace, post of responsibility). We analyzed transcript content using an inductive approach.</p></div><div><h3>Results</h3><p>Factors identified by doctors were classified into three themes: 1) superior diagnostic capability of the MRI compared to other imaging modalities has favoured MRI use and inclusion in Clinical Practice Guidelines; 2) patient demands, owing to lower trust and acceptance of doctors’ judgment than to technology-based medicine, leads to patient-doctor relationships that result unnecessary MRI test; 3) structural or contextual aspects of the health system, such as excessive rotation of doctors or a lack of time to carry out a thorough patient examination, which disempower doctors and favour overuse.</p></div><div><h3>Conclusions</h3><p>Doctors identified non-clinical factors that affect MRI use and that lead to unintended consequences both for the healthcare system and for patients. We recommend an organizational approach to give doctors enough resources to overcome non-clinical factors that lead to excessive MRI orders in order to optimize its use.</p></div>","PeriodicalId":48672,"journal":{"name":"Health Policy and Technology","volume":"12 4","pages":"Article 100816"},"PeriodicalIF":6.0,"publicationDate":"2023-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"50197903","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The opportunities and challenges of women's digital health: A research agenda 女性数字健康的机遇与挑战:研究议程
IF 6 3区 医学 Q1 HEALTH POLICY & SERVICES Pub Date : 2023-10-05 DOI: 10.1016/j.hlpt.2023.100814
Caroline A Figueroa , Josephine Sundqvist , Sunjoy Mathieu , Nasim Farrokhnia , Diane Nevin , Sarah Wamala Andersson
{"title":"The opportunities and challenges of women's digital health: A research agenda","authors":"Caroline A Figueroa ,&nbsp;Josephine Sundqvist ,&nbsp;Sunjoy Mathieu ,&nbsp;Nasim Farrokhnia ,&nbsp;Diane Nevin ,&nbsp;Sarah Wamala Andersson","doi":"10.1016/j.hlpt.2023.100814","DOIUrl":"https://doi.org/10.1016/j.hlpt.2023.100814","url":null,"abstract":"","PeriodicalId":48672,"journal":{"name":"Health Policy and Technology","volume":"12 4","pages":"Article 100814"},"PeriodicalIF":6.0,"publicationDate":"2023-10-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"50197901","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
E-Prescription: A practical application of information and communications technology in perspective of Bangladesh 电子处方:从孟加拉国的角度看信息和通信技术的实际应用
3区 医学 Q1 HEALTH POLICY & SERVICES Pub Date : 2023-10-01 DOI: 10.1016/j.hlpt.2023.100810
M. A. Khan, Md. Rabiul Islam, Asif Rahman, Afsana Mim, Rasel Ahmmed
The healthcare management authorities are responsible for delivering convenient services to the patients. The traditional healthcare management system is quite old and impractical in many cases, including a physical visit. Additionally, the COVID-19 epidemic makes the existing system unattainable, which creates an uncomfortable situation for visiting doctor's chambers that is risky both for doctors and patients. An electronic-prescription (e-prescription) management system can switch the existing one to the online appointment and doctor consulting system. Many developed countries have already adopted such e-prescription management systems, although low-and-middle-income countries (LMICs) like Bangladesh are apathetic. So implementing e-prescription management systems in all countries, including Bangladesh, is the demand of time, especially when information and communication technologies (ICT) are at hand. We design, develop and test an ICT-based online doctor and patient management system utilizing the latest software and web development tools. In the developed e-prescription management system, the patient can visit their profile to make an appointment according to their need and doctor's availability. After that, the patient consults with the doctor based on the appointment's approval by the admin panel. Finally, the patient receives an online e-prescription and collects the medicine from a registered pharmacy with access to the online e-prescription. The e-prescription management system records patient history, including e-prescription, making handling patients easy. The proper use of the developed e-prescription management system will solve many existing problems of the existing healthcare management system, including many concerns that arise due to the advent of COVID-19.
医疗保健管理机构负责为患者提供便利的服务。传统的医疗保健管理系统在很多情况下都是相当陈旧和不切实际的,包括身体检查。再加上新型冠状病毒感染症(COVID-19)的扩散,使现有的制度变得难以实现,这给医生和患者带来了很大的风险。电子处方管理系统可以将现有的电子处方管理系统转换为网上预约和医生咨询系统。许多发达国家已经采用了这种电子处方管理系统,尽管孟加拉国等低收入和中等收入国家对此漠不关心。因此,在包括孟加拉国在内的所有国家实施电子处方管理系统是时间的要求,特别是在掌握信息和通信技术(ICT)的情况下。我们利用最新的软件和网络开发工具设计、开发和测试一个基于信息通信技术的在线医生和病人管理系统。在开发的电子处方管理系统中,患者可以根据自己的需要和医生的空闲时间访问自己的个人资料进行预约。之后,患者根据管理小组批准的预约向医生咨询。最后,患者收到在线电子处方,并从可访问在线电子处方的注册药房取药。电子处方管理系统记录了患者的历史,包括电子处方,使处理患者变得容易。正确使用开发的电子处方管理系统将解决现有医疗管理系统存在的许多问题,包括由于COVID-19的出现而产生的许多担忧。
{"title":"E-Prescription: A practical application of information and communications technology in perspective of Bangladesh","authors":"M. A. Khan, Md. Rabiul Islam, Asif Rahman, Afsana Mim, Rasel Ahmmed","doi":"10.1016/j.hlpt.2023.100810","DOIUrl":"https://doi.org/10.1016/j.hlpt.2023.100810","url":null,"abstract":"The healthcare management authorities are responsible for delivering convenient services to the patients. The traditional healthcare management system is quite old and impractical in many cases, including a physical visit. Additionally, the COVID-19 epidemic makes the existing system unattainable, which creates an uncomfortable situation for visiting doctor's chambers that is risky both for doctors and patients. An electronic-prescription (e-prescription) management system can switch the existing one to the online appointment and doctor consulting system. Many developed countries have already adopted such e-prescription management systems, although low-and-middle-income countries (LMICs) like Bangladesh are apathetic. So implementing e-prescription management systems in all countries, including Bangladesh, is the demand of time, especially when information and communication technologies (ICT) are at hand. We design, develop and test an ICT-based online doctor and patient management system utilizing the latest software and web development tools. In the developed e-prescription management system, the patient can visit their profile to make an appointment according to their need and doctor's availability. After that, the patient consults with the doctor based on the appointment's approval by the admin panel. Finally, the patient receives an online e-prescription and collects the medicine from a registered pharmacy with access to the online e-prescription. The e-prescription management system records patient history, including e-prescription, making handling patients easy. The proper use of the developed e-prescription management system will solve many existing problems of the existing healthcare management system, including many concerns that arise due to the advent of COVID-19.","PeriodicalId":48672,"journal":{"name":"Health Policy and Technology","volume":"15 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134934267","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
VALIDATE approach on medication adequacy clinical decision support systems: Holistic assessment for optimal technology adoption 药物充足性临床决策支持系统的有效方法:最佳技术采用的整体评估
IF 6 3区 医学 Q1 HEALTH POLICY & SERVICES Pub Date : 2023-09-27 DOI: 10.1016/j.hlpt.2023.100811
Carla Fernández-Barceló , Elena Calvo-Cidoncha , Laura Sampietro-Colom
<div><h3>Introduction</h3><p>Lately, Health Technology Assessment (HTA) has narrowed its scope to analyses of mainly clinical and economic benefits. Recent challenges emphasize the need for holistic assessments to obtain accurate recommendations for decision-making considering empirical facts and stakeholder's values. VALIDATE approach considers stakeholder's views and empirical facts allowing for more comprehensive HTAs. This study frames the assessment for clinical decision support systems (CDSS) using VALIDATE.</p></div><div><h3>Methods</h3><p>A systematic review of the literature was conducted to gather evidence on the CDSS's effectiveness and published stakeholder perspectives. Considering the retrieved information, semi-structured interviews with stakeholders were conducted to uncover issues around CDSSs such as problem definition regarding the occurrence of medication errors, judgement of existing preventive methods and previous experiences with CDSSs, background theories regarding thoughts on future impact and personal beliefs, and barriers/facilitators for implementation.</p></div><div><h3>Results</h3><p>When including multi-stakeholder views, reasons different from the literature are shown to interfere with CDSS acceptance/implementation, such as: i) Occurrence of ME (no traceability of medication taken/poor patient empowerment), ii) Technology as a tool to prevent ME (insufficient if only implemented at one point-of-care), iii) Previous experiences with CDSSs (low CDSSs development due to drug prescription being lastly digitalized in hospitals) and iv) CDSSs metrics (data inputted should be measured to control CDSSs performance).</p></div><div><h3>Conclusion</h3><p>Including multi-stakeholders views in scoping technology evaluation brings added value and new information for the assessment, resulting in more comprehensive assessment; otherwise, it can lead to inaccurate information resulting in inaccurate decisions on if, when and how to adopt CDSS.</p></div><div><h3>Public Interest Summary</h3><p>Including varied stakeholders into health technology assessment provides a deeper understanding of what value can a technology bring in. The present study develops a framework to assess clinical decision support systems (CDSS) considering different stakeholders. They were interviewed to understand their perspective on different parts of the problem CDSSs try to solve (medication errors) and the solution itself (CDSSs). Some reasons on the interviews were different from the literature published so far, that are shown to hinder CDSS acceptance/implementation, such as: no traceability of medication taken/poor patient empowerment, CDSSs being insufficient if only implemented at one point-of-care, low CDSSs development due to drug prescription being lastly digitalized in hospitals and CDSS metrics (data inputted should be measured to control CDSSs performance). This approach can improve both implementation chances and posterior assessment of CDSSs.
引言最近,卫生技术评估(HTA)已将其范围缩小到主要分析临床和经济效益。最近的挑战强调需要进行全面评估,以获得准确的决策建议,同时考虑到经验事实和利益攸关方的价值观。VALIDATE方法考虑了利益相关者的观点和经验事实,从而实现更全面的HTA。本研究使用VALIDATE对临床决策支持系统(CDSS)进行了评估。方法对文献进行了系统回顾,以收集有关CDSS有效性和已发表的利益相关者观点的证据。考虑到检索到的信息,对利益相关者进行了半结构化访谈,以揭示围绕CDSS的问题,如关于药物错误发生的问题定义、对现有预防方法的判断和以前使用CDSS的经验、关于对未来影响的思考和个人信念的背景理论,以及执行方面的障碍/促进者。结果当包括多方利益相关者的观点时,与文献不同的原因被证明会干扰CDSS的接受/实施,例如:i)脑脊髓炎的发生(所服用药物的可追溯性/患者能力差),ii)作为预防脑脊髓炎工具的技术(如果仅在一个护理点实施,则不足),iii)CDSS的以往经验(由于医院最终将处方数字化,CDSS发展较低)和iv)CDSS指标(应测量输入的数据以控制CDSS的性能)。结论在范围界定技术评估中纳入多利益相关者的观点为评估带来了附加值和新信息,从而实现更全面的评估;否则,它可能会导致信息不准确,从而导致是否、何时以及如何采用CDSS的决策不准确。公共利益总结将不同的利益相关者纳入卫生技术评估,可以更深入地了解技术能带来什么价值。本研究开发了一个考虑不同利益相关者的临床决策支持系统(CDSS)评估框架。他们接受了采访,以了解他们对CDSS试图解决的问题(药物错误)和解决方案本身(CDSS)的不同部分的看法。访谈中的一些原因与迄今为止发表的文献不同,这些原因被证明阻碍了CDSS的接受/实施,例如:所服用的药物没有可追溯性/患者能力较差,CDSS如果只在一个护理点实施是不够的,由于药物处方在医院最后数字化和CDSS指标(应测量输入的数据以控制CDSS的性能),CDSS的发展较低。这种方法可以提高CDSS的实施机会和后验评估。
{"title":"VALIDATE approach on medication adequacy clinical decision support systems: Holistic assessment for optimal technology adoption","authors":"Carla Fernández-Barceló ,&nbsp;Elena Calvo-Cidoncha ,&nbsp;Laura Sampietro-Colom","doi":"10.1016/j.hlpt.2023.100811","DOIUrl":"https://doi.org/10.1016/j.hlpt.2023.100811","url":null,"abstract":"&lt;div&gt;&lt;h3&gt;Introduction&lt;/h3&gt;&lt;p&gt;Lately, Health Technology Assessment (HTA) has narrowed its scope to analyses of mainly clinical and economic benefits. Recent challenges emphasize the need for holistic assessments to obtain accurate recommendations for decision-making considering empirical facts and stakeholder's values. VALIDATE approach considers stakeholder's views and empirical facts allowing for more comprehensive HTAs. This study frames the assessment for clinical decision support systems (CDSS) using VALIDATE.&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Methods&lt;/h3&gt;&lt;p&gt;A systematic review of the literature was conducted to gather evidence on the CDSS's effectiveness and published stakeholder perspectives. Considering the retrieved information, semi-structured interviews with stakeholders were conducted to uncover issues around CDSSs such as problem definition regarding the occurrence of medication errors, judgement of existing preventive methods and previous experiences with CDSSs, background theories regarding thoughts on future impact and personal beliefs, and barriers/facilitators for implementation.&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Results&lt;/h3&gt;&lt;p&gt;When including multi-stakeholder views, reasons different from the literature are shown to interfere with CDSS acceptance/implementation, such as: i) Occurrence of ME (no traceability of medication taken/poor patient empowerment), ii) Technology as a tool to prevent ME (insufficient if only implemented at one point-of-care), iii) Previous experiences with CDSSs (low CDSSs development due to drug prescription being lastly digitalized in hospitals) and iv) CDSSs metrics (data inputted should be measured to control CDSSs performance).&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Conclusion&lt;/h3&gt;&lt;p&gt;Including multi-stakeholders views in scoping technology evaluation brings added value and new information for the assessment, resulting in more comprehensive assessment; otherwise, it can lead to inaccurate information resulting in inaccurate decisions on if, when and how to adopt CDSS.&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Public Interest Summary&lt;/h3&gt;&lt;p&gt;Including varied stakeholders into health technology assessment provides a deeper understanding of what value can a technology bring in. The present study develops a framework to assess clinical decision support systems (CDSS) considering different stakeholders. They were interviewed to understand their perspective on different parts of the problem CDSSs try to solve (medication errors) and the solution itself (CDSSs). Some reasons on the interviews were different from the literature published so far, that are shown to hinder CDSS acceptance/implementation, such as: no traceability of medication taken/poor patient empowerment, CDSSs being insufficient if only implemented at one point-of-care, low CDSSs development due to drug prescription being lastly digitalized in hospitals and CDSS metrics (data inputted should be measured to control CDSSs performance). This approach can improve both implementation chances and posterior assessment of CDSSs.","PeriodicalId":48672,"journal":{"name":"Health Policy and Technology","volume":"12 4","pages":"Article 100811"},"PeriodicalIF":6.0,"publicationDate":"2023-09-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"50197902","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Future challenges and opportunities for cancer screening in the COVID-19 era COVID-19时代癌症筛查的未来挑战和机遇
IF 6 3区 医学 Q1 HEALTH POLICY & SERVICES Pub Date : 2023-09-17 DOI: 10.1016/j.hlpt.2023.100808
Mojtaba Nouhi , Leon Bijlmakers , Zahra Goudarzi , Samira Alipour , Seyyed Mostafa Hakimzadeh , Pedram Nazari , Reza Jahangiri , Majid Heydari

Objectives

The COVID-19 pandemic undermines health service provision and poses threats to health systems in general. This study aims to investigate the early and long-term effects of COVID-19 on cancer screening.

Method

We conducted a scoping review, in which we nested the Futures Wheel (FW) method and the Future Polygon (FP) method. PubMed, SCOPUS, and Web of Sciences databases were searched electronically to identify relevant studies published between 1 January 2020 and 25 July 2023. The FW method was applied to identify the early and long-term effects; the FP was applied during a focus group discussion with a group of experts with a view to estimating the lag time between COVID-19 and its effects on cancer screening.

Results

A total of 79 studies met the inclusion criteria. We identified 31 early effects and 26 long-term effects of COVID-19, and divided them into four clusters: screening centers, at-risk persons, screening methods, and clinical staff. The first long-term effects of COVID-19 involve a tendency to shift from hospital-based to home-based screening, accompanied by an acceleration in the application of remote screening methods and emerging psychological problems among clinical staff. This may result in an increase in the number of people with serious oncological conditions, more intensive use of advanced therapeutic interventions, higher expenditure and worsening of treatment outcomes.

Conclusion

The effects of COVID-19 on cancer screening and its long-term effects on cancer treatment and its outcomes are ominous. A redesign of cancer screening programs may be required so as to make them more flexible and resilient to external shocks.

COVID-19大流行破坏了卫生服务的提供,并对整个卫生系统构成威胁。本研究旨在探讨COVID-19对癌症筛查的早期和长期影响。我们进行了范围审查,其中我们嵌套了未来轮(FW)方法和未来多边形(FP)方法。以电子方式检索PubMed、SCOPUS和Web of Sciences数据库,以确定2020年1月1日至2023年7月25日之间发表的相关研究。采用FW法鉴定早期和远期效应;在与一组专家进行的焦点小组讨论中应用了该计划,目的是估计COVID-19及其对癌症筛查的影响之间的滞后时间。共有79项研究符合纳入标准。我们确定了31个COVID-19的早期效应和26个长期效应,并将其分为四个集群:筛查中心、高危人群、筛查方法和临床工作人员。COVID-19的第一个长期影响是,人们倾向于从以医院为基础的筛查转向以家庭为基础的筛查,同时远程筛查方法的应用加速,以及临床工作人员中新出现的心理问题。这可能导致患有严重肿瘤疾病的人数增加,更密集地使用先进的治疗干预措施,增加支出和治疗结果恶化。COVID-19对癌症筛查的影响及其对癌症治疗及其结果的长期影响是不祥的。可能需要重新设计癌症筛查项目,使其对外部冲击更具灵活性和弹性。
{"title":"Future challenges and opportunities for cancer screening in the COVID-19 era","authors":"Mojtaba Nouhi ,&nbsp;Leon Bijlmakers ,&nbsp;Zahra Goudarzi ,&nbsp;Samira Alipour ,&nbsp;Seyyed Mostafa Hakimzadeh ,&nbsp;Pedram Nazari ,&nbsp;Reza Jahangiri ,&nbsp;Majid Heydari","doi":"10.1016/j.hlpt.2023.100808","DOIUrl":"10.1016/j.hlpt.2023.100808","url":null,"abstract":"<div><h3>Objectives</h3><p>The COVID-19 pandemic undermines health service provision and poses threats to health systems in general. This study aims to investigate the early and long-term effects of COVID-19 on cancer screening.</p></div><div><h3>Method</h3><p>We conducted a scoping review, in which we nested the Futures Wheel (FW) method and the Future Polygon (FP) method. PubMed, SCOPUS, and Web of Sciences databases were searched electronically to identify relevant studies published between 1 January 2020 and 25 July 2023. The FW method was applied to identify the early and long-term effects; the FP was applied during a focus group discussion with a group of experts with a view to estimating the lag time between COVID-19 and its effects on cancer screening.</p></div><div><h3>Results</h3><p>A total of 79 studies met the inclusion criteria. We identified 31 early effects and 26 long-term effects of COVID-19, and divided them into four clusters: screening centers, at-risk persons, screening methods, and clinical staff. The first long-term effects of COVID-19 involve a tendency to shift from hospital-based to home-based screening, accompanied by an acceleration in the application of remote screening methods and emerging psychological problems among clinical staff. This may result in an increase in the number of people with serious oncological conditions, more intensive use of advanced therapeutic interventions, higher expenditure and worsening of treatment outcomes.</p></div><div><h3>Conclusion</h3><p>The effects of COVID-19 on cancer screening and its long-term effects on cancer treatment and its outcomes are ominous. A redesign of cancer screening programs may be required so as to make them more flexible and resilient to external shocks.</p></div>","PeriodicalId":48672,"journal":{"name":"Health Policy and Technology","volume":"12 4","pages":"Article 100808"},"PeriodicalIF":6.0,"publicationDate":"2023-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135348048","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Adapting evidence-informed peri-discharge complex interventions in reducing 30-day hospital readmissions for heart failure and COPD 采用循证出院期复杂干预措施,减少心力衰竭和慢性阻塞性肺病患者30天再入院率
IF 6 3区 医学 Q1 HEALTH POLICY & SERVICES Pub Date : 2023-09-16 DOI: 10.1016/j.hlpt.2023.100804
Claire CW Zhong , Charlene HL Wong , Chi-tim Hung , Eng-kiong Yeoh , Eliza LY Wong , Vincent CH Chung

Objective

To select and refine evidence-informed peri-discharge complex interventions(abbrev. Interventions) for reducing 30-day hospital readmissions among Heart Failure(HF) and COPD patients in Hong Kong public healthcare system context using GRADE Evidence to Decision(EtD) framework.

Methods

Two 18-participant panels were recruited to carry out a two-step process for both conditions. In Step 1, participants were invited to prioritize Interventions and suggest important combinations of Interventions. In Step 2, based on the priority lists, participants were invited to conduct a two-round Delphi study for generating consensus-based Interventions for reducing 30-day hospital readmissions. GRADE EtD framework was used to guide the decision-making process, taking into consideration of benefits, harms, values and preferences, equity, acceptability, and feasibility.

Results

Five out of ten Interventions reached positive consensus for HF, while six reached positive consensus for COPD. Case management, discharge planning, patient education, self-management, and telephone follow-up were common components, and were considered as core elements for reducing 30-day hospital readmissions among HF and COPD patients in Hong Kong. Preliminary implementation issues mainly included governance and leadership, financing, health workforce development, service access and readiness, as well as empowerment of patients and caregivers.

Conclusions

This study successfully applied the GRADE EtD framework for starting the adaptation process of complex interventions and established a list of local stakeholders-endorsed Interventions for reducing 30-day hospital readmissions for HF and COPD in Hong Kong. Before implementing and maintaining these endorsed Interventions at scale in local context, further research to improve intervention-context fit as well as piloting and evaluation is necessary.

选择和完善循证出院期复杂干预措施(简称。干预措施)在香港公共医疗系统背景下使用GRADE证据到决策(EtD)框架减少心力衰竭(HF)和慢性阻塞性肺病患者30天再入院率。招募了两个18名参与者的小组,对这两种情况进行两步处理。在步骤1中,参与者被邀请对干预措施进行优先排序,并建议重要的干预措施组合。在步骤2中,根据优先级列表,邀请参与者进行两轮德尔菲研究,以产生基于共识的干预措施,以减少30天的再入院率。使用GRADE EtD框架来指导决策过程,考虑到利益、危害、价值和偏好、公平性、可接受性和可行性。10项干预措施中有5项对心力衰竭达成积极共识,而6项对慢性阻塞性肺病达成积极共识。病例管理、出院计划、患者教育、自我管理和电话随访是常见的组成部分,被认为是减少香港HF和COPD患者30天再入院的核心要素。初步实施问题主要包括治理和领导、筹资、卫生人力发展、服务获取和准备,以及增强患者和护理人员的权能。本研究成功应用GRADE EtD框架启动复杂干预措施的适应过程,并建立了一份由本地利益相关者认可的干预措施清单,以减少香港心力衰竭和慢性阻塞性肺病患者30天的再入院率。在当地大规模实施和维持这些认可的干预措施之前,有必要进一步研究以改善干预措施与环境的契合度,并进行试点和评估。
{"title":"Adapting evidence-informed peri-discharge complex interventions in reducing 30-day hospital readmissions for heart failure and COPD","authors":"Claire CW Zhong ,&nbsp;Charlene HL Wong ,&nbsp;Chi-tim Hung ,&nbsp;Eng-kiong Yeoh ,&nbsp;Eliza LY Wong ,&nbsp;Vincent CH Chung","doi":"10.1016/j.hlpt.2023.100804","DOIUrl":"10.1016/j.hlpt.2023.100804","url":null,"abstract":"<div><h3>Objective</h3><p>To select and refine evidence-informed peri-discharge complex interventions(abbrev. <em>Interventions</em><span>) for reducing 30-day hospital readmissions among Heart Failure(HF) and COPD patients in Hong Kong public healthcare system context using GRADE Evidence to Decision(EtD) framework.</span></p></div><div><h3>Methods</h3><p>Two 18-participant panels were recruited to carry out a two-step process for both conditions. In Step 1, participants were invited to prioritize <em>Interventions</em> and suggest important combinations of <em>Interventions</em>. In Step 2, based on the priority lists, participants were invited to conduct a two-round Delphi study for generating consensus-based <em>Interventions</em> for reducing 30-day hospital readmissions. GRADE EtD framework was used to guide the decision-making process, taking into consideration of benefits, harms, values and preferences, equity, acceptability, and feasibility.</p></div><div><h3>Results</h3><p>Five out of ten <em>Interventions</em> reached positive consensus for HF, while six reached positive consensus for COPD. Case management, discharge planning, patient education, self-management, and telephone follow-up were common components, and were considered as core elements for reducing 30-day hospital readmissions among HF and COPD patients in Hong Kong. Preliminary implementation issues mainly included governance and leadership, financing, health workforce development, service access and readiness, as well as empowerment of patients and caregivers.</p></div><div><h3>Conclusions</h3><p>This study successfully applied the GRADE EtD framework for starting the adaptation process of complex interventions and established a list of local stakeholders-endorsed <em>Interventions</em> for reducing 30-day hospital readmissions for HF and COPD in Hong Kong. Before implementing and maintaining these endorsed <em>Interventions</em> at scale in local context, further research to improve intervention-context fit as well as piloting and evaluation is necessary.</p></div>","PeriodicalId":48672,"journal":{"name":"Health Policy and Technology","volume":"12 4","pages":"Article 100804"},"PeriodicalIF":6.0,"publicationDate":"2023-09-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135348909","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Current evidence on the use of mHealth approaches in Sub-Saharan Africa: A scoping review 撒哈拉以南非洲使用移动医疗方法的当前证据:范围审查
IF 6 3区 医学 Q1 HEALTH POLICY & SERVICES Pub Date : 2023-09-16 DOI: 10.1016/j.hlpt.2023.100806
Genet Tadese Aboye , Martijn Vande Walle , Gizeaddis Lamesgin Simegn , Jean-Marie Aerts

Background

Mobile health (mHealth) approaches are especially beneficial to Sub-Saharan Africa (SSA), which has a disproportionate disease burden and a scarcity of healthcare workers.

Objective

This study aims to assess the availability, stage, and targeted health issues of mHealth interventions in SSA and to identify the gaps.

Methods

The study employed a scoping review guided by Arksey and O'Malley's framework to explore the use of mHealth in SSA. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) was used to report the review in a transparent and comprehensive manner. Articles published from 2000 to 2021 were searched in PUBMED, IEEE, SCOPUS, and Web of Science and evaluated with set of inclusion criteria. Data from the included publications were retrieved and synthesized.

Results

A total of 1020 articles were found. 59 of these have met the criteria for inclusion. The results show the implementation of mHealth interventions in 21 SSA nations. Only 1 (2%) mHealth interventions used a wearable sensor-based approach. 13 (22%) were SMS text-based interventions, 17 (29%) were app-based mHealth approaches, 18 (30%) were telemedicine-based approaches, and 10 (17%) were mixed approaches. HIV, cancer, and maternal and child health problems are the most commonly discussed health issues. Proof of concept, design and development, a pilot test were the frequently documented stages of mHealth interventions.

Conclusion

Less than half of SSA countries incorporate mHealth platforms, highlighting the need for further development. Integrating wearable based platforms for real-time monitoring of physiological parameters demands careful consideration.

Public Interest Summary

Mobile health (mHealth) technology is believed to be very beneficial for Sub-Saharan Africa (SSA) nations where there is a high disease burden but  inadequate healthcare system. Evidence-based data on the use and implementation of mHealth systems is needed to trace implementation and fill existing gaps. We performed a scoping review to determine the current availability, use, and stage of mHealth interventions and targeted health services in SSA. 21 SSA nations made (few) attempts in designing and implementing of mHealth systems. HIV, cancer, and maternal and child health are some of the health services among others. Though few large-scale implementations were reported, most interventions are at an early stage. mHealth solution should be designed to be both economical and simple to use to increase its uptake and incorporate wearables for real-time monitoring of physiological parameters.

移动医疗(mHealth)方法对撒哈拉以南非洲(SSA)尤其有益,因为该地区疾病负担过重,卫生保健工作者稀缺。本研究旨在评估SSA移动医疗干预措施的可用性、阶段和针对性健康问题,并确定差距。该研究采用了Arksey和O'Malley的框架指导下的范围审查,以探索移动医疗在SSA中的使用。使用系统评价和荟萃分析范围评价扩展首选报告项目(PRISMA-ScR)以透明和全面的方式报告评价。在PUBMED, IEEE, SCOPUS和Web of Science中检索2000年至2021年发表的文章,并根据一套纳入标准进行评估。从纳入的出版物中检索和合成数据。共发现1020篇文章。其中59个国家符合列入标准。结果显示移动医疗干预措施在21个SSA国家的实施情况。只有1项(2%)移动医疗干预使用了基于可穿戴传感器的方法。13例(22%)是基于短信的干预措施,17例(29%)是基于应用程序的移动健康方法,18例(30%)是基于远程医疗的方法,10例(17%)是混合方法。艾滋病毒、癌症和孕产妇和儿童健康问题是最常讨论的健康问题。概念验证、设计和开发、试点测试是移动医疗干预措施经常记录的阶段。只有不到一半的南撒哈拉国家采用了移动医疗平台,这凸显了进一步发展的必要性。整合基于可穿戴平台的生理参数实时监测需要慎重考虑。移动医疗(mHealth)技术被认为对撒哈拉以南非洲(SSA)国家非常有益,这些国家的疾病负担高,但卫生保健系统不足。需要关于移动卫生系统使用和实施的循证数据,以追踪实施情况并填补现有空白。我们进行了一项范围审查,以确定SSA移动健康干预措施和目标卫生服务的当前可用性、使用情况和阶段。21个SSA国家(很少)尝试设计和实施移动医疗系统。除其他外,艾滋病毒、癌症和妇幼保健是一些保健服务。虽然很少有大规模实施的报告,但大多数干预措施都处于早期阶段。移动健康解决方案的设计应既经济又易于使用,以增加其吸收,并纳入可穿戴设备,以实时监测生理参数。
{"title":"Current evidence on the use of mHealth approaches in Sub-Saharan Africa: A scoping review","authors":"Genet Tadese Aboye ,&nbsp;Martijn Vande Walle ,&nbsp;Gizeaddis Lamesgin Simegn ,&nbsp;Jean-Marie Aerts","doi":"10.1016/j.hlpt.2023.100806","DOIUrl":"10.1016/j.hlpt.2023.100806","url":null,"abstract":"<div><h3>Background</h3><p>Mobile health (mHealth) approaches are especially beneficial to Sub-Saharan Africa (SSA), which has a disproportionate disease burden and a scarcity of healthcare workers.</p></div><div><h3>Objective</h3><p>This study aims to assess the availability, stage, and targeted health issues of mHealth interventions in SSA and to identify the gaps.</p></div><div><h3>Methods</h3><p>The study employed a scoping review guided by Arksey and O'Malley's framework to explore the use of mHealth in SSA. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) was used to report the review in a transparent and comprehensive manner. Articles published from 2000 to 2021 were searched in PUBMED, IEEE, SCOPUS, and Web of Science and evaluated with set of inclusion criteria. Data from the included publications were retrieved and synthesized.</p></div><div><h3>Results</h3><p>A total of 1020 articles were found. 59 of these have met the criteria for inclusion. The results show the implementation of mHealth interventions in 21 SSA nations. Only 1 (2%) mHealth interventions used a wearable sensor-based approach. 13 (22%) were SMS text-based interventions, 17 (29%) were app-based mHealth approaches, 18 (30%) were telemedicine-based approaches, and 10 (17%) were mixed approaches. HIV, cancer, and maternal and child health problems are the most commonly discussed health issues. Proof of concept, design and development, a pilot test were the frequently documented stages of mHealth interventions.</p></div><div><h3>Conclusion</h3><p>Less than half of SSA countries incorporate mHealth platforms, highlighting the need for further development. Integrating wearable based platforms for real-time monitoring of physiological parameters demands careful consideration.</p></div><div><h3>Public Interest Summary</h3><p>Mobile health (mHealth) technology is believed to be very beneficial for Sub-Saharan Africa (SSA) nations where there is a high disease burden but  inadequate healthcare system. Evidence-based data on the use and implementation of mHealth systems is needed to trace implementation and fill existing gaps. We performed a scoping review to determine the current availability, use, and stage of mHealth interventions and targeted health services in SSA. 21 SSA nations made (few) attempts in designing and implementing of mHealth systems. HIV, cancer, and maternal and child health are some of the health services among others. Though few large-scale implementations were reported, most interventions are at an early stage. mHealth solution should be designed to be both economical and simple to use to increase its uptake and incorporate wearables for real-time monitoring of physiological parameters.</p></div>","PeriodicalId":48672,"journal":{"name":"Health Policy and Technology","volume":"12 4","pages":"Article 100806"},"PeriodicalIF":6.0,"publicationDate":"2023-09-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2211883723000825/pdfft?md5=9370a35f12f646886dd0c8ab3ead2271&pid=1-s2.0-S2211883723000825-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135347253","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Health Policy and Technology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1